EP1576101A4 - Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer - Google Patents

Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer

Info

Publication number
EP1576101A4
EP1576101A4 EP03733900A EP03733900A EP1576101A4 EP 1576101 A4 EP1576101 A4 EP 1576101A4 EP 03733900 A EP03733900 A EP 03733900A EP 03733900 A EP03733900 A EP 03733900A EP 1576101 A4 EP1576101 A4 EP 1576101A4
Authority
EP
European Patent Office
Prior art keywords
chloroplasts
polypeptides
expressing
expression
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03733900A
Other languages
German (de)
English (en)
Other versions
EP1576101A2 (fr
Inventor
Stephen P Mayfield
Scott Franklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of EP1576101A2 publication Critical patent/EP1576101A2/fr
Publication of EP1576101A4 publication Critical patent/EP1576101A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C12N15/821—Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
    • C12N15/8212—Colour markers, e.g. beta-glucoronidase [GUS], green fluorescent protein [GFP], carotenoid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP03733900A 2002-04-23 2003-04-23 Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer Withdrawn EP1576101A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37512902P 2002-04-23 2002-04-23
US375129P 2002-04-23
US43495702P 2002-12-19 2002-12-19
US434957P 2002-12-19
PCT/US2003/012997 WO2003091413A2 (fr) 2002-04-23 2003-04-23 Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer

Publications (2)

Publication Number Publication Date
EP1576101A2 EP1576101A2 (fr) 2005-09-21
EP1576101A4 true EP1576101A4 (fr) 2007-10-31

Family

ID=29273018

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03733900A Withdrawn EP1576101A4 (fr) 2002-04-23 2003-04-23 Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer

Country Status (10)

Country Link
US (1) US20040014174A1 (fr)
EP (1) EP1576101A4 (fr)
JP (1) JP2005537784A (fr)
KR (1) KR101107380B1 (fr)
CN (1) CN1886512B (fr)
AU (1) AU2003239182B2 (fr)
CA (1) CA2483337C (fr)
IL (1) IL164549A (fr)
MX (1) MXPA04010432A (fr)
WO (1) WO2003091413A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2003002461A1 (es) * 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
JP4742258B2 (ja) * 2005-02-04 2011-08-10 国立大学法人名古屋大学 葉緑体で機能するホタルルシフェラーゼ遺伝子とそれを用いた葉緑体遺伝子発現のリアルタイムモニタリング
WO2007133558A2 (fr) * 2006-05-09 2007-11-22 The Scripps Research Institute Expression vigoureuse d'une protéine mammalienne bioactive dans des chloroplastes de chlamydomonas
JP2010517558A (ja) * 2007-02-09 2010-05-27 サントル ナショナル ドゥ ラ ルシェルシュ スィヤンティフィック（セーエヌエルエス） オストレオコッカス（Ｏｓｔｒｅｏｃｏｃｃｕｓ）種の核ゲノムからのポリペプチドの発現
WO2008150461A2 (fr) 2007-06-01 2008-12-11 Sapphire Energy Criblage haut rendement d'organismes de photosynthèse génétiquement modifiés
AU2008299020A1 (en) * 2007-09-11 2009-03-19 Sapphire Energy, Inc. Molecule production by photosynthetic organisms
NZ583620A (en) * 2007-09-11 2012-08-31 Sapphire Energy Inc Methods of producing organic fuel products with photosynthetic organisms
US20090176272A1 (en) * 2007-09-12 2009-07-09 Kuehnle Agrosystems, Inc. Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria
US20100050301A1 (en) * 2007-10-05 2010-02-25 Sapphire Energy, Inc. System for capturing and modifying large pieces of genomic dna and constructing vascular plants with synthetic chloroplast genomes
US20090269816A1 (en) * 2007-10-05 2009-10-29 Sapphire Energy, Inc. System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts
US8314222B2 (en) * 2007-10-05 2012-11-20 Sapphire Energy, Inc. System for capturing and modifying large pieces of genomic DNA and constructing organisms with chloroplasts
EP2220125A4 (fr) * 2007-11-13 2010-12-29 Sapphire Energy Inc Production de polypeptides hybrides fc dans des algues eucaryotes
CA2705289A1 (fr) * 2007-11-13 2009-05-22 The Scripps Research Institute Production de fusion anticorps-toxine cytotoxique dans une algue eucaryotique
ES2475973T3 (es) 2008-06-27 2014-07-11 Sapphire Energy, Inc. Inducción de la floculaci�n en organismos fotosint�ticos
CA2746441C (fr) 2008-12-10 2018-05-15 Synthetic Genomics, Inc. Production d'alcools a chaine ramifiee par des micro-organismes photosynthetiques
EP2381761A4 (fr) * 2008-12-31 2012-06-20 Sapphire Energy Inc Algues génétiquement modifiées résistant aux herbicides
BRPI1008958A2 (pt) * 2009-03-11 2015-09-01 Sapphire Energy Inc Produção de biocombustível em procariotas e eucariotas
PL2248825T3 (pl) * 2009-05-04 2013-04-30 Ribovax Biotechnologies Sa Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu
US8956834B2 (en) 2009-06-29 2015-02-17 Synthetic Genomics, Inc. Acyl-ACP thioesterase genes and uses therefor
US8633002B2 (en) 2009-08-11 2014-01-21 Synthetic Genomics, Inc. Microbial production of fatty alcohols
JP2013529058A (ja) * 2010-02-25 2013-07-18 バイオグロウ インク． 細菌ｌｕｘオペロンを含む自己発光植物とそれを作製する方法
JP2011217662A (ja) * 2010-04-08 2011-11-04 Senshukai Co Ltd 改変型ルシフェラーゼを大量発現する葉緑体形質転換植物
EP2655625B1 (fr) 2010-12-23 2017-01-18 ExxonMobil Research and Engineering Company Polypeptides présentant une activité lipolytique, microorganismes recombinés contenant acides nucleiques codant pour des polypeptides présentant une activité lipolytique et production d'acides gras et de dérivés d'acides gras.
PT2655648T (pt) 2010-12-23 2018-04-16 Exxonmobil Res & Eng Co Microrganismos geneticamente modificados compreendendo 4-hidroxibenzoil-coa tioesterases e métodos de utilização dos mesmos para produzir ácidos gordos livres e derivados de ácidos gordos e 4-hidroxibenzoil-coa tioesterases
WO2012087673A1 (fr) 2010-12-23 2012-06-28 Exxonmobil Research And Engineering Company Acyl-acp thioestérases procaryotes pour la production d'acides gras dans des microorganismes génétiquement modifiés
EP2658963A4 (fr) 2010-12-31 2014-05-14 Exxonmobil Res & Eng Co Amélioration du procédé de production de biomasse par perturbation des voies de dissipation de l'énergie lumineuse
US9096834B2 (en) 2012-02-24 2015-08-04 Exxonmobil Research And Engineering Company Recombinant microorganisms comprising thioesterase and lysophosphatidic acid acyltransferase genes for fatty acid production
US9181568B2 (en) 2012-04-23 2015-11-10 Exxonmobil Research And Engineering Company Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
EP2660324A1 (fr) 2012-05-02 2013-11-06 Algenics Production d'anticorps thérapeutiques sécrétés dans des micro-algues
EP2660323A1 (fr) 2012-05-02 2013-11-06 Algenics Production d'anticorps thérapeutiques sécrétés dans des microalgues phaeodctylum tricornutum
EP2844760A1 (fr) 2012-05-02 2015-03-11 Algenics Production d'anticorps thérapeutiques sécrétés dans des microalgues
EP2909304A4 (fr) 2012-10-16 2016-09-21 Exxonmobil Res & Eng Co Gènes de dgat et procédés d'utilisation pour la production de triglycéride dans des microorganismes recombinés
US8835149B2 (en) 2012-12-06 2014-09-16 Exxonmobil Research And Engineering Company DGAT genes comprising pleckstrin homology domains and methods of use for triglyceride production in recombinant microorganisms
WO2014089533A2 (fr) 2012-12-06 2014-06-12 Synthetic Genomics, Inc. Mutants d'algue ayant un phénotype d'acclimatation à la lumière intense inclus
KR101633159B1 (ko) * 2013-11-28 2016-06-23 부경대학교 산학협력단 클라미도모나스 유래 활성 펩타이드를 유효성분으로 포함하는 위장 질환 치료 및 예방용 조성물
US20170267984A1 (en) 2016-03-18 2017-09-21 Exxonmobil Research And Engineering Company Chlorophyllase overproduction to enhance photosynthetic efficiency
WO2017165788A1 (fr) * 2016-03-24 2017-09-28 Marquette University Marqueurs fluorescents flagellaires quantitatifs et étalons
WO2018098001A1 (fr) 2016-11-27 2018-05-31 Triton Algae Innovations, Inc. Procédé de purification d'ostéopontine de recombinaison à partir de microalgues
US10612031B2 (en) * 2017-02-09 2020-04-07 Dow Agrosciences Llc Eukaryotic cell-free protein expression system that does not require an artificial energy regeneration system
CN115948450B (zh) * 2022-08-01 2024-02-13 深圳大学 一种莱茵衣藻叶绿体-酿酒酵母-大肠杆菌穿梭载体及其构建方法与应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024493A1 (fr) * 1994-03-11 1995-09-14 Calgene Inc. Expression amelioree dans un plaste de plante
WO2000007431A1 (fr) * 1998-08-03 2000-02-17 Rutgers, The State University Of New Jersey Elements de regulation de traduction pour expression de proteine de niveau eleve dans les plastes de plantes superieures et leurs procedes d'utilisation
WO2001072959A2 (fr) * 2000-03-01 2001-10-04 Auburn University Proteines pharmaceutiques, agents therapeutiques humains, albumine serique humaine, insuline, et toxique b de cholera natif soumis a des plastes transgeniques

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567600A (en) * 1983-09-26 1996-10-22 Mycogen Plant Sciences, Inc. Synthetic insecticidal crystal protein gene
GB2200118A (en) * 1987-01-23 1988-07-27 Allelix Inc Synthetic chymosin-and prochymosin-encoding DNA segments
US5082767A (en) * 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
US5661017A (en) * 1993-09-14 1997-08-26 Dunahay; Terri Goodman Method to transform algae, materials therefor, and products produced thereby
US5545818A (en) * 1994-03-11 1996-08-13 Calgene Inc. Expression of Bacillus thuringiensis cry proteins in plant plastids
US6110668A (en) * 1996-10-07 2000-08-29 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Gene synthesis method
USRE39350E1 (en) * 1997-01-17 2006-10-17 The Scripps Research Institute RNA binding protein and binding site useful for expression of recombinant molecules
EA200000926A1 (ru) * 1998-03-11 2001-06-25 Новартис Аг Экспрессия генов биосинтеза трегалозы в растениях
ATE360072T1 (de) * 1998-07-10 2007-05-15 Calgene Llc Expression eukarotischer peptide in pflanzenplastiden
US6271444B1 (en) * 1998-07-10 2001-08-07 Calgene Llc Enhancer elements for increased translation in plant plastids
PL347904A1 (en) * 1998-10-07 2002-04-22 Syngenta Participations Ag Therapeutically active proteins in plants
AU2001245358A1 (en) * 2000-02-29 2001-09-12 Auburn University Production of antibodies in transgenic plastids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024493A1 (fr) * 1994-03-11 1995-09-14 Calgene Inc. Expression amelioree dans un plaste de plante
WO2000007431A1 (fr) * 1998-08-03 2000-02-17 Rutgers, The State University Of New Jersey Elements de regulation de traduction pour expression de proteine de niveau eleve dans les plastes de plantes superieures et leurs procedes d'utilisation
WO2001072959A2 (fr) * 2000-03-01 2001-10-04 Auburn University Proteines pharmaceutiques, agents therapeutiques humains, albumine serique humaine, insuline, et toxique b de cholera natif soumis a des plastes transgeniques

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
FRANKLIN, S., ET AL.: "Development of a GFP reporter gene for chlamydomonas reinhardtii chloroplast", THE PLANT JOURNAL, vol. 30, no. 6, June 2002 (2002-06-01), pages 733 - 744, XP002440617 *
MALIGA P: "Engineering the plastid genome of higher plants", CURRENT OPINION IN PLANT BIOLOGY, QUADRANT SUBSCRIPTION SERVICES, GB, vol. 5, no. 2, 1 April 2002 (2002-04-01), pages 164 - 172, XP002995930, ISSN: 1369-5266, DOI: 10.1016/S1369-5266(02)00248-0 *
MAYFIELD STEPHEN P ET AL: "Expression and assembly of a fully active antibody in algae.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 100, no. 2, 21 January 2003 (2003-01-21), pages 438 - 442, XP002440629, ISSN: 0027-8424 *
MINKO I ET AL: "Renilla luciferase as a vital reporter for chloroplast gene expression in Chlamydomonas", MOLECULAR AND GENERAL GENETICS, vol. 262, no. 3, October 1999 (1999-10-01), pages 421 - 425, XP002440616, ISSN: 0026-8925 *
NAKAMURA ET AL.: "chloroplast Chlamydomonas reinhardtii [gbpln]: 93 CDS's (26731 codons)", 1999, Retrieved from the Internet <URL:http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=3055.chloroplast> *
TON GIAO ET AL: "Construction of the anti-cocaine Fab genes for expression in the unicellular green alga Chlamydomonas reinhardtii", FASEB JOURNAL, vol. 16, no. 4, 20 March 2002 (2002-03-20), & ANNUAL MEETING OF THE PROFESSIONAL RESEARCH SCIENTISTS ON EXPERIMENTAL BIOLOGY; NEW ORLEANS, LOUISIANA, USA; APRIL 20-24, 2002, pages A542, XP008171334, ISSN: 0892-6638 *

Also Published As

Publication number Publication date
IL164549A (en) 2010-12-30
CA2483337A1 (fr) 2003-11-06
KR20040106384A (ko) 2004-12-17
AU2003239182A1 (en) 2003-11-10
AU2003239182B2 (en) 2008-11-06
KR101107380B1 (ko) 2012-01-19
IL164549A0 (en) 2005-12-18
US20040014174A1 (en) 2004-01-22
JP2005537784A (ja) 2005-12-15
MXPA04010432A (es) 2005-05-27
WO2003091413A2 (fr) 2003-11-06
CA2483337C (fr) 2015-10-27
CN1886512B (zh) 2015-11-25
EP1576101A2 (fr) 2005-09-21
WO2003091413A3 (fr) 2006-06-29

Similar Documents

Publication Publication Date Title
EP1576101A4 (fr) Expression de polypeptides dans des chloroplastes, et compositions et procedes permettant de les exprimer
NO20030079D0 (no) Kontrollsammensetninger og fremgangsmåter for anvendelse ved koagulasjonsanalyser
EP1682150A4 (fr) Compositions et procedes pour induire la differenciation cellulaire
EP1570069A4 (fr) Compositions et procedes de dedifferentiation cellulaire et de regeneration de tissus
EP1660663A4 (fr) Procedes et compositions pour la regeneration des tissus
EP1928453A4 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
EP1812031A4 (fr) Compositions et procedes de modification de biomolecules
DK1877090T3 (da) Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
EP1562422A4 (fr) Compositions et methodes de prolongement de la survie des plaquettes
EP1868633A4 (fr) Compositions et procedes permettant d&#39;inhiber les proteines dishevelled
EP1651053A4 (fr) Compositions et procedes pour compositions de pates surgelees pretes a cuire
IS8394A (is) 2-pýridónafleiður sem daukyrningselastasatálmar og notkun þeirra
IS8381A (is) 2-pýridónafleiður sem daufkyrningselastasatálmar og notkun þeirra
EP1567230A4 (fr) Compositions permettant d&#39;eliminer les taches sur des surfaces dentaires, procedes d&#39;elaboration et d&#39;utilisation correspondants
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK1495128T3 (da) Forstærket proteinekspression i Bacillus
EP1553960A4 (fr) Procedes et compositions a base de neureguline pour traiter les maladies cardio-vasculaires
PT103029B (pt) Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo paraa sua preparacao
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
IS8069A (is) Aðferðir og lyfjasamsetningar til að ná áreiðanlega ásættanlegum testósterónstyrk
IL197531A0 (en) Genetically programmed expression of selectively sulfated proteins in eubacteria
EP1850665A4 (fr) Agents permettant de lutter contre la carpocapse des pommes et des poires dans les vergers
FI20085245L (fi) Leukamurskain ja omalla käyttövoimalla liikkuva murskain
NO20051875D0 (no) Kjoleror og fremgangsmate for bruk av dette
NO20054095D0 (no) Pyridyloksymetyl og benzioksazolazabicyklisk derivater

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041027

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/82 20060101AFI20060816BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A01H 5/00 20060101ALI20070704BHEP

Ipc: C12N 15/82 20060101AFI20060816BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20071001

17Q First examination report despatched

Effective date: 20081205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160721